Guobang Pharmaceutical (605507.SH) announced its results for the first three quarters, with net profit of 579 million yuan, an increase of 18.36% over the previous year

Zhitongcaijing · 10/18 08:09

According to Zhitong Finance App News, Guobang Pharmaceutical (605507.SH) released its report for the third quarter of 2024. The company's revenue for the first three quarters was 4.418 billion yuan, up 9.00% year on year; net profit attributable to shareholders of listed companies was 579 million yuan, up 18.36% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 565 million yuan, up 16.87% year on year; basic earnings per share were 1.04 yuan/share.